JP2022534902A5 - - Google Patents

Info

Publication number
JP2022534902A5
JP2022534902A5 JP2021570180A JP2021570180A JP2022534902A5 JP 2022534902 A5 JP2022534902 A5 JP 2022534902A5 JP 2021570180 A JP2021570180 A JP 2021570180A JP 2021570180 A JP2021570180 A JP 2021570180A JP 2022534902 A5 JP2022534902 A5 JP 2022534902A5
Authority
JP
Japan
Prior art keywords
alkyl
cycloalkyl
groups
ring
optionally substituted
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
JP2021570180A
Other languages
English (en)
Japanese (ja)
Other versions
JP2022534902A (ja
JP7675020B2 (ja
Filing date
Publication date
Application filed filed Critical
Priority claimed from PCT/US2020/035564 external-priority patent/WO2021002986A2/en
Publication of JP2022534902A publication Critical patent/JP2022534902A/ja
Publication of JP2022534902A5 publication Critical patent/JP2022534902A5/ja
Priority to JP2025010128A priority Critical patent/JP2025066800A/ja
Application granted granted Critical
Publication of JP7675020B2 publication Critical patent/JP7675020B2/ja
Active legal-status Critical Current
Anticipated expiration legal-status Critical

Links

JP2021570180A 2019-05-31 2020-06-01 Bax阻害剤およびその使用 Active JP7675020B2 (ja)

Priority Applications (1)

Application Number Priority Date Filing Date Title
JP2025010128A JP2025066800A (ja) 2019-05-31 2025-01-23 Bax阻害剤およびその使用

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US201962855185P 2019-05-31 2019-05-31
US62/855,185 2019-05-31
PCT/US2020/035564 WO2021002986A2 (en) 2019-05-31 2020-06-01 Bax inhibitors and uses thereof

Related Child Applications (1)

Application Number Title Priority Date Filing Date
JP2025010128A Division JP2025066800A (ja) 2019-05-31 2025-01-23 Bax阻害剤およびその使用

Publications (3)

Publication Number Publication Date
JP2022534902A JP2022534902A (ja) 2022-08-04
JP2022534902A5 true JP2022534902A5 (https=) 2023-06-08
JP7675020B2 JP7675020B2 (ja) 2025-05-12

Family

ID=74100581

Family Applications (2)

Application Number Title Priority Date Filing Date
JP2021570180A Active JP7675020B2 (ja) 2019-05-31 2020-06-01 Bax阻害剤およびその使用
JP2025010128A Pending JP2025066800A (ja) 2019-05-31 2025-01-23 Bax阻害剤およびその使用

Family Applications After (1)

Application Number Title Priority Date Filing Date
JP2025010128A Pending JP2025066800A (ja) 2019-05-31 2025-01-23 Bax阻害剤およびその使用

Country Status (6)

Country Link
US (1) US12479857B2 (https=)
EP (1) EP3976009A4 (https=)
JP (2) JP7675020B2 (https=)
AU (1) AU2020299526B2 (https=)
CA (1) CA3142424A1 (https=)
WO (1) WO2021002986A2 (https=)

Families Citing this family (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU2020299526B2 (en) 2019-05-31 2026-01-29 Case Western Reserve University Bax inhibitors and uses thereof
EP4479383A4 (en) * 2022-02-17 2026-01-07 Sunnybrook Res Inst ISOQUINOLINE DERIVATIVES USED AS BAX AND/OR BAK INHIBITORS, COMPOSITIONS AND ASSOCIATED USES
KR102896033B1 (ko) * 2022-12-22 2025-12-04 연세대학교 산학협력단 N-벤질퀴나졸린-4-아민 화합물을 포함하는, 비만 및 지질 관련 대사성 질환의 예방 또는 치료용 조성물
WO2024208292A1 (zh) * 2023-04-04 2024-10-10 江苏亚虹医药科技股份有限公司 泛素特异性蛋白酶1抑制剂、其制备方法及其医药用途
CN120882721A (zh) * 2023-07-28 2025-10-31 双翼原创(上海)医药有限公司 Arf1抑制剂及其应用
CN120554372A (zh) * 2024-02-27 2025-08-29 浙江养生堂天然药物研究所有限公司 嘧啶并杂芳类化合物及其应用

Family Cites Families (18)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4798824A (en) 1985-10-03 1989-01-17 Wisconsin Alumni Research Foundation Perfusate for the preservation of organs
US4879283A (en) 1985-10-03 1989-11-07 Wisconsin Alumni Research Foundation Solution for the preservation of organs
RU2025973C1 (ru) 1992-02-10 1995-01-09 Научно-производственное предприятие "Биофарм" Раствор для консервации живых органов
US5552267A (en) 1992-04-03 1996-09-03 The Trustees Of Columbia University In The City Of New York Solution for prolonged organ preservation
US5370989A (en) 1992-04-03 1994-12-06 The Trustees Of Columbia University In The City Of New York Solution for prolonged organ preservation
AU664074B2 (en) 1992-06-26 1995-11-02 Torii Pharmaceutical Co., Ltd. Organ preserving fluid
US5405742A (en) 1993-07-16 1995-04-11 Cyromedical Sciences, Inc. Solutions for tissue preservation and bloodless surgery and methods using same
US6046206A (en) * 1995-06-07 2000-04-04 Cell Pathways, Inc. Method of treating a patient having a precancerous lesions with amide quinazoline derivatives
US6969720B2 (en) 1999-03-17 2005-11-29 Amr Technology, Inc. Biaryl substituted purine derivatives as potent antiproliferative agents
EP1125925A1 (en) 2000-02-15 2001-08-22 Applied Research Systems ARS Holding N.V. Amine derivatives for the treatment of apoptosis
GB0220187D0 (en) 2002-08-30 2002-10-09 Novartis Ag Organic compounds
WO2012079079A1 (en) 2010-12-10 2012-06-14 President And Fellows Of Harvard College Production of induced pluripotent stem cells
WO2014005186A1 (en) 2012-07-06 2014-01-09 Newsouth Innovations Pty Limited Methods for inhibiting neuron apoptosis and necrosis
EP2938610A2 (en) 2012-12-28 2015-11-04 The U.S.A. as represented by the Secretary, Department of Health and Human Services Inhibitors of the usp1/uaf1 deubiquitinase complex and uses thereof
US10519160B2 (en) 2014-07-18 2019-12-31 The General Hospital Corporation Imaging agents for neural flux
WO2018019284A1 (en) 2016-07-28 2018-02-01 Realinn Life Science Limited Compounds for enhancing bax/bcl-2 expression and activity and therapeutic use thereof
AU2020299526B2 (en) 2019-05-31 2026-01-29 Case Western Reserve University Bax inhibitors and uses thereof
JP7674020B1 (ja) * 2024-07-19 2025-05-09 株式会社大都技研 遊技台

Similar Documents

Publication Publication Date Title
JP2022534902A5 (https=)
JP2021512150A5 (https=)
JP2023052069A5 (https=)
JP2021523221A5 (https=)
JP2021516240A5 (https=)
JP2005535586A5 (https=)
JP2007524696A5 (https=)
JP2013507425A5 (https=)
JP2017502940A5 (https=)
JP2018526367A5 (https=)
JP2016515560A5 (https=)
RU2014114466A (ru) ИНДАЗОЛ-3-КАРБОКСАМИДЫ И ИХ ПРИМЕНЕНИЕ В КАЧЕСТВЕ ИНГИБИТОРОВ СИГНАЛЬНОГО ПУТИ WNT/β-КАТЕНИНА
JP2017518959A5 (https=)
JP2016525075A5 (https=)
JP2014521688A5 (https=)
JP2016522172A5 (https=)
JP2021535164A5 (https=)
JP2002529532A5 (https=)
JP2018525375A5 (https=)
JP2013509392A5 (https=)
JP2016528273A5 (https=)
JP2020521766A5 (https=)
RU2016120610A (ru) Производное сульфонамида и его применение в медицине
JP2019527724A5 (https=)
JP2020511547A5 (https=)